Brief quote from Bob Lanza on Ocata acquisition by Astellas - The Niche
I asked Ocata CSO, Bob Lanza, for a comment on the big news of the acquisition of the company by Astellas. Here’s what he had to say: “I can say that this is an exciting time for regenerative medicine. The [...]